Date published: 2025-10-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

GABA (CAS 56-12-2)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
4-Aminobutyric acid
Application:
GABA is an inhibitory neurotransmitter in the CNS
CAS Number:
56-12-2
Purity:
≥98%
Molecular Weight:
103.12
Molecular Formula:
C4H9NO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

GABA is the major inhibitory neurotransmitter in the mammalian central nervous system. GABA is an activator of GABA Receptor. GABA is a neurotransmitter present in the central nervous system (CNS) of mammals. Functioning as an inhibitory neurotransmitter, GABA exerts a calming influence on the brain and nervous system. It participates in various physiological processes, encompassing mood regulation, motor control, and cognitive functions. Acting through two types of receptors, namely gamma-Aminobutyric acid-A and gamma-Aminobutyric acid-B, GABA′s activity is modulated by diverse drugs and hormones.


GABA (CAS 56-12-2) References

  1. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.  |  Werhahn, KJ., et al. 1999. J Physiol. 517 (Pt 2): 591-7. PMID: 10332104
  2. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.  |  Dalby, NO. 2000. Neuropharmacology. 39: 2399-407. PMID: 10974324
  3. A new role for GABA: inhibition of tumor cell migration.  |  Ortega, A. 2003. Trends Pharmacol Sci. 24: 151-4. PMID: 12706998
  4. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.  |  Fink-Jensen, A., et al. 1992. Eur J Pharmacol. 220: 197-201. PMID: 1425991
  5. Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures.  |  Thompson, SM. and Gähwiler, BH. 1992. J Neurophysiol. 67: 1698-701. PMID: 1629773
  6. GABA: a dominant neurotransmitter in the hypothalamus.  |  Decavel, C. and Van den Pol, AN. 1990. J Comp Neurol. 302: 1019-37. PMID: 2081813
  7. Advantages of an antagonist: bicuculline and other GABA antagonists.  |  Johnston, GA. 2013. Br J Pharmacol. 169: 328-36. PMID: 23425285
  8. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.  |  Tyzio, R., et al. 2014. Science. 343: 675-9. PMID: 24503856
  9. Comparing GABA-dependent physiological measures of inhibition with proton magnetic resonance spectroscopy measurement of GABA using ultra-high-field MRI.  |  Dyke, K., et al. 2017. Neuroimage. 152: 360-370. PMID: 28284797
  10. Modification of orientation sensitivity of cat visual cortex neurons by removal of GABA-mediated inhibition.  |  Tsumoto, T., et al. 1979. Exp Brain Res. 34: 351-63. PMID: 421752
  11. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.  |  Suzdak, PD. and Jansen, JA. 1995. Epilepsia. 36: 612-26. PMID: 7555976
  12. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats.  |  Coenen, AM., et al. 1995. Epilepsy Res. 21: 89-94. PMID: 7588592
  13. GABAc receptors: relatively simple transmitter -gated ion channels?  |  Johnston, GA. 1996. Trends Pharmacol Sci. 17: 319-23. PMID: 8885697
  14. GABA and its receptors in the spinal cord.  |  Malcangio, M. and Bowery, NG. 1996. Trends Pharmacol Sci. 17: 457-62. PMID: 9014500

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

GABA, 10 g

sc-203053
10 g
$63.00

GABA, 25 g

sc-203053A
25 g
$133.00

GABA, 5 kg

sc-203053B
5 kg
$450.00

GABA, 10 kg

sc-203053C
10 kg
$750.00